EGM
VYGR icon

Engineers Gate Manager’s Voyager Therapeutics VYGR Stock Holding History

Engineers Gate Manager’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-11,460
Closed -$88.8K – 2290
2023
Q3 		$88.8K Sell
11,460
-11,370
-50% -$104K ﹤0.01% 1609
2023
Q2 		$261K Buy
+22,830
New +$236K 0.01% 1361
2022
Q3 		– Sell
-11,737
Closed -$69K – 2109
2022
Q2 		$69K Buy
+11,737
New +$79.3K ﹤0.01% 1773
2021
Q2 		– Sell
-36,600
Closed -$172K – 2054
2021
Q1 		$172K Buy
+36,600
New +$250K 0.01% 1633
2020
Q3 		– Sell
-18,533
Closed -$234K – 2010
2020
Q2 		$234K Sell
18,533
-10,791
-37% -$126K 0.01% 1359
2020
Q1 		$268K Buy
29,324
+7,842
+37% +$90K 0.02% 1108
2019
Q4 		$300K Buy
21,482
+9,270
+76% +$135K 0.01% 1258
2019
Q3 		$210K Buy
+12,212
New +$256K 0.01% 1182

Other funds holding VYGR

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Engineers Gate Manager's VYGR Position: Q4 2023 in Review

Engineers Gate Manager sold out of Voyager Therapeutics (VYGR) in Q4 2023, closing a stake of 11,460 shares — an estimated $88.8K sold.

Engineers Gate Manager first reported a position in VYGR in Q3 2019 and held it in 8 quarters. The position peaked at $300K in Q4 2019. 107 funds tracked by Wall St. Rank hold VYGR as of Q4 2023.

  • Engineers Gate Manager reported no remaining Voyager Therapeutics position as of Q4 2023 after selling out during the quarter.
  • Engineers Gate Manager sold 11,460 Voyager Therapeutics shares in Q4 2023, an estimated $88.8K.
  • Engineers Gate Manager first reported a position in Voyager Therapeutics in Q3 2019 and held it in 8 quarters.
  • Engineers Gate Manager's Voyager Therapeutics position peaked at $300K in Q4 2019.
  • 107 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q4 2023.

Based on Engineers Gate Manager's 13F filing for Q4 2023, filed 14 Feb 2024.